Additional Resources for Physicians
Updated: June 14, 2010
Patients diagnosed with alpha-1 antitrypsin deficiency should be referred to the following resources:
Alpha-1 Canada is committed to providing information and support to people affected by alpha-1 antitrypsin deficiency; informing the medical community about alpha-1 antitrypsin deficiency; and to generating broad awareness about this genetic liver, lung and skin disease.
Please refer your patients to Alpha-1 Canada for information, education and support.
1638 Northway Avenue, Windsor, ON N9B 3L9
|Toll Free: 1-888-669-4583
|Fax: 519-258-1614 or 1-888-669-4583
For further information, physicians can also contact the organizations above as well as members of the Alpha-1 Canada Medical Advisory Board at 1-888-669-4583.
Medical Advisory Board
Alpha-1 Canada is pleased and proud to have four of Canada’s leading researchers and clinicians in the field of alpha-1 antitrypsin deficiency as members of our Medical Advisory Board. They are:
Dr. Kenneth R. Chapman, MD, MSc, FRCPC, FACP, FCCP, Chair
Dr. Chapman is the Chair of the Medical Advisory Board, a Professor of Medicine at the University of Toronto and an internationally respected researcher in the field of asthma and airway diseases. Dr. Chapman is also Director of the Canadian Registry for Alpha-1 Antitrypsin Deficiency.
Dr. Jean Bourbeau, MD, MSc
Dr. Bourbeau is an associate professor in the Department of Medicine and the Department of Epidemiology and Biostatistics and Occupational Health at McGill University in Montreal.
Dr. Diane W. Cox, PhD, FCCMG, FRSC
Dr. Cox is both Professor and Founding Chair of the Department of Medical Genetics at the University of Alberta in Edmonton. Dr. Cox has a long involvement in studies of alpha-1 antitrypsin deficiency.
Dr. Simon Ling, MB, ChB
Dr. Ling is Assistant Professor of Paediatrics at the Hospital for Sick Children, University of Toronto. Dr. Ling collaborates in studies of the genetic determinants of liver disease due to cystic fibrosis and alpha-1 antitrypsin deficiency.